Literature DB >> 14570628

Propofol decreases reperfusion-induced arrhythmias in a model of "border zone" between normal and ischemic-reperfused guinea pig myocardium.

Jean-Luc Hanouz1, Alexandra Yvon, Frédéric Flais, René Rouet, Pierre Ducouret, Henri Bricard, Jean-Louis Gérard.   

Abstract

UNLABELLED: We examined the effect of propofol on the main mechanisms involved in ischemia/reperfusion-induced arrhythmias (i.e., spontaneous arrhythmias, conduction blocks, and dispersion of repolarization) in vitro. In a double-chamber bath, guinea pig right ventricular muscle strips were subjected to 30 min of simulated ischemia followed by 30 min of reperfusion (altered zone; AZ) and to standard conditions (normal zone; NZ). Action potential (AP) parameters were recorded in the NZ and AZ. We studied the effects of Intralipid(R) and of propofol at 10(-6), 10(-5), and 2 x 10(-5) M on the occurrence of spontaneous sustained arrhythmias, conduction blocks, and the dispersion of repolarization. In NZ, Intralipid and propofol did not significantly modify the AP parameters. Propofol, but not Intralipid, lessened the ischemia-induced decrease in AP duration (APD) at 90% of repolarization (APD(90)) and attenuated the APD dispersion around the "border zone." Propofol did not modify the occurrence of ischemia-induced arrhythmias. Propofol 10(-6) M, but not Intralipid or propofol at 10(-5) and 2 x 10(-5) M, decreased the occurrence of ischemia-induced conduction blocks. Propofol decreased the occurrence of reperfusion-induced spontaneous sustained arrhythmias. We conclude that, in vitro, propofol attenuated the ischemia-induced APD(90) dispersion around the "border zone" and decreased the occurrence of spontaneous arrhythmias related to myocardial reperfusion injury. IMPLICATIONS: In isolated guinea pig ventricular myocardium propofol, but not Intralipid(R), attenuated the ischemia-induced shortening of action potential and, thus, the dispersion of repolarization and decreased the occurrence of spontaneous ventricular arrhythmia related to reperfusion injury. This result may be important for propofol-based anesthesia in patients at high risk for intraoperative ischemia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14570628     DOI: 10.1213/01.ane.0000086731.87098.99

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  3 in total

Review 1.  Propofol and arrhythmias: two sides of the coin.

Authors:  Qiang Liu; Ai-ling Kong; Rong Chen; Cheng Qian; Shao-wen Liu; Bao-gui Sun; Le-xin Wang; Long-sheng Song; Jiang Hong
Journal:  Acta Pharmacol Sin       Date:  2011-06       Impact factor: 6.150

2.  Mitochondrial involvement in propofol-induced cardioprotection: An in vitro study in human myocardium.

Authors:  Sandrine Lemoine; Lan Zhu; Steeve Gress; Jean-Louis Gérard; Stéphane Allouche; Jean-Luc Hanouz
Journal:  Exp Biol Med (Maywood)       Date:  2016-01-08

3.  Inhibition of the cardiac Na⁺ channel α-subunit Nav1.5 by propofol and dexmedetomidine.

Authors:  Carsten Stoetzer; Svenja Reuter; Thorben Doll; Nilufar Foadi; Florian Wegner; Andreas Leffler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-12-15       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.